CD8A and neoplasm: The combination of PD-1 NVs and gemcitabine significantly promoted the peripheral blood mononuclear cell (PBMC) activation, inhibited the proliferation of triple-negative breast cancer, induced the cancer cell apoptosis, increasing the infiltrated CD8+ T cells, delaying the tumor growth, and prolonging the survival of tumor-bearing mice.